We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




New Technique for Restoring Heart Rhythm

By HospiMedica International staff writers
Posted on 09 Aug 2011
A new technique that uses low-power electrical impulses to treat cardiac arrhythmias such as atrial fibrillation (AF) could lead to the development of painless defibrillation methods.

Researchers at the ENS Lyon physics laboratory (France) and the Max Planck Institute for Dynamics and Self-Organization (Göttingen, Germany) used a conventional cardiac catheter to study the effects of Low-Energy Anti-fibrillation Pacing (LEAP) on AF. More...
They applied a series of five low-intensity impulses to the heart of an animal suffering from arrhythmia; after a few seconds, the heart started to beat regularly again. The technique is based on the same principle as existing defibrillators, but it elicits a different response in the heart. Shortly after the shock, the cardiac tissue can no longer transmit electrical signals; the chaotic activity stops, and the heart can then resume its normal functioning. The use of a lower electric field necessitates that the shock be repeated several times.

Additionally, since it uses low electric fields, the new LEAP technique should be less painful and less damaging to cardiac tissue than existing defibrillators, reducing the energy needed for defibrillation by 80%. It also offers the advantage of restoring heart rhythm more gradually than current techniques. Each impulse activates more tissue, gradually eliminating any turbulent cardiac activity. The blood vessels and other cardiac heterogeneities, such as the misalignment of heart fibers, act as control centers: once activated, they make it possible to "reprogram" the heart. The next step is to test the technique on human patients. The study was published in the July 13, 2011, issue of Nature.

“Demonstrated on animals for atrial fibrillation, these results could also apply to the treatment of ventricular fibrillation, a fatal form of arrhythmia,” concluded study coauthor physicist Alain Pumir, PhD, of ENS Lyon. “LEAP could make it possible to eliminate pain while improving the treatment's success rate, in addition to prolonging the life of the batteries used to power implanted or external defibrillators.”

AF is characterized by the uncoordinated action of certain cells in the cardiac muscle tissue. As a result, chaotic electrical impulses propagate in the heart, preventing regular contractions and hampering the organ's capacity to circulate blood throughout the organism. Since it is not possible to reduce AF and restore normal heart rhythm by medication alone, the most effective treatment is still the application of an external electrical shock using a defibrillator. Although brief, the high-intensity impulse can damage the tissues and it is often perceived as being very painful. Until now, it was considered impossible to reduce the intensity without running the risk of an unsuccessful defibrillation.

Related Links:

ENS Lyon physics laboratory
Max Planck Institute for Dynamics and Self-Organization



Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Emergency Ventilator
Shangrila935
Radiation Safety Barrier
RayShield Intensi-Barrier
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The fiber in the brain implant is less than half a millimeter thick (Photo courtesy of Peter Aagaard Brixen)

Brain Implant Records Neural Signals and Delivers Precise Medication

Neurological diseases such as epilepsy involve complex interactions across multiple layers of the brain, yet current implants can typically stimulate or record activity from only a single point.... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.